BUSINESS● LOWAug 13 · Aug 13, 2026, 11:57 AM
Karyopharm Therapeutics reports mixed Q2 results; reaffirms FY26 outlook
Seeking Alpha Tech
Karyopharm Therapeutics released its mixed second-quarter financial results and reaffirmed its financial outlook for fiscal year 2026. This reports on the company's financial performance and future projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS31m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech